Enhancing menaquinone‐7 biosynthesis by optimized fermentation strategies and fed‐batch cultivation of food‐derived Bacillus subtilis
Journal of the Science of Food and Agriculture · 30.08.2025 · 105 (11) · 5973-5985
DOI: 10.1002/jsfa.14320 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Journal of the Science of Food and Agriculture, online erschienen am 23.05.2025. Verfasst von Hui Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: SKL of Marine FooSid Processing and Safety Control, National Engineering Research Center of Seafood, Collaborative Innovation Center of Seafood Deep …. Hauptthemen laut MEDLINE: Bacillus subtilis, Vitamin K 2, Batch Cell Culture Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: the Key R & D Program of Shanxi Province, the National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND Menaquinone‐7 (MK‐7), a type of vitamin K 2 (VK 2 ), is considered to be a health‐promoting functional ingredient in the current recommended dietary supply. However, it is a challenge to isolate high‐yield MK‐7‐producing strains with reasonable safety from natural food, which further limits their use as starter culture. RESULTS In this study, an MK‐7 production strain derived from commercial natto with a yield of 2.33 ± 0.06 mg L −1 , Bacillus subtilis 4‐b4, was screened using a selective medium containing rotenone combined with a VK 2 enzyme‐linked immunosorbent assay kit, and high‐performance liquid chromatography. This strain exhibited excellent safety with no hemolysis, excellent antioxidant activity, and sensitivity to antibiotics. Furthermore, its fermentation strategies (fermentation condition and the supply of key precursor substances) were optimized to improve MK‐7 biosynthesis. As a result, the yield increased 3.31‐fold, reaching 7.70 ± 0.24 mg L −1 at shake flask fermentation level. After scaling up through fed‐batch fermentation, the yield further increased to 23.43 ± 0.41 mg L −1 in a 5 L bioreactor. CONCLUSION The current study developed a strain with good safety and antibiotic sensitivity for producing MK‐7, and improved its biosynthesis through optimized fermentation strategies and scaling up the process, laying the foundation for the availability of biologically active MK‐7 fermented food in the food industry. © 2025 Society of Chemical Industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- SKL of Marine FooSid Processing and Safety Control, National Engineering Research Center of Seafood, Collaborative Innovation Center of Seafood Deep Processing, School of Food Science and Technology, Dalian Polytechnic…
ORCID-Profile: Sufang Zhang
Förderung
- the Key R & D Program of Shanxi Province
- the National Natural Science Foundation of China
Zitieren
APA
Guo, H., Xue, S., Dong, N., Zhang, Y., Dai, Y., Chen, Y., & Zhang, S. (2025). Enhancing menaquinone‐7 biosynthesis by optimized fermentation strategies and fed‐batch cultivation of food‐derived Bacillus subtilis. Journal of the Science of Food and Agriculture, 105(11), 5973-5985. https://doi.org/10.1002/jsfa.14320
Vancouver
Guo H, Xue S, Dong N, Zhang Y, Dai Y, Chen Y, et al. Enhancing menaquinone‐7 biosynthesis by optimized fermentation strategies and fed‐batch cultivation of food‐derived Bacillus subtilis. Journal of the Science of Food and Agriculture. 2025;105(11):5973-5985. doi:10.1002/jsfa.14320
BibTeX
@article{Guo2025,
author = {Guo, Hui and Xue, Siyu and Dong, Naihui and Zhang, Yujiao and Dai, Yiwei and Chen, Yingxi and Zhang, Sufang},
title = {Enhancing menaquinone‐7 biosynthesis by optimized fermentation strategies and fed‐batch cultivation of food‐derived Bacillus subtilis},
journal = {Journal of the Science of Food and Agriculture},
year = {2025},
volume = {105},
number = {11},
pages = {5973--5985},
doi = {10.1002/jsfa.14320}
}
EUVIMED